Head of Global Product Supply
EligibilityRemote, United States only
Languages
$290k–$340k/yr
Company profile
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Its antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI.
1 observationLast observed
1 open role